Cargando...
Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis
BACKGROUND: The adjuvant use of mitotane on adrenocortical carcinoma (ACC) has always been in controversy. We aimed to assess the prognostic benefits of adjuvant mitotane after resection of ACC in patients without distant metastasis. METHODS: The PubMed, WoS, Embase, and Cochrane Library databases w...
Gardado en:
| Publicado en: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6008618/ https://ncbi.nlm.nih.gov/pubmed/29967789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9362108 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|